BioBlast Pharma (ORPN) Prices Common Stock, Warrants Direct Offering for Proceeds of $6.7M Mar 17, 2016 07:03AM
Notable Analyst Rating Changes 1/28: (HAL) (KMI) (NMBL) Upgraded; (ROK) (SEIC) (TRIP) Downgraded Jan 28, 2016 10:46AM
Rodman & Renshaw Starts Bio Blast Pharma (ORPN) at Buy, PT $25 Jan 28, 2016 07:52AM